Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673462 · ClinicalTrials.gov registry record · Phase 3
Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
A Phase 3 study, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,797
- Enrollment target
NCT03673462 is a Phase 3 study that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 2,797 participants.
The verdict
NCT03673462, a Phase 3 study, has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,797 participants
- Enrollment target
Study Summary
The primary objective of this study was to describe the safety profile of Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid (MenACYW) Conjugate Vaccine and Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 (MENVEO®) Conjugate Vaccine when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers.
Interventions
- BIOLOGICAL Pneumococcal 13-valent Conjugate Vaccine
- BIOLOGICAL Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)
- BIOLOGICAL Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®)
- BIOLOGICAL Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine
- BIOLOGICAL Rotavirus Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,797 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2023-03-16 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03673462
The ClinicalTrials.gov registry entry for NCT03673462 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,797 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Pneumococcal 13-valent Conjugate Vaccine is the first listed.
NCT03673462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03673462 about?
NCT03673462 is a clinical study titled "Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers". The primary objective of this study was to describe the safety profile of Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid (MenACYW) Conjugate Vaccine and Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 (MENVEO®) Conjugate Vaccine when administered c...
What is the current status of trial NCT03673462?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,797 participants. The study started on 2018-09-17. Estimated completion is 2023-03-16.
What interventions are being tested in trial NCT03673462?
The interventions under investigation include: Pneumococcal 13-valent Conjugate Vaccine (BIOLOGICAL), Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine) (BIOLOGICAL), Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®) (BIOLOGICAL), Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine (BIOLOGICAL), Rotavirus Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT03673462?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.